MGM Faces Legal Scrutiny Over Barry Diller’s $48.30/Share Bid

What happened

A law firm has launched an investigation into Barry Diller’s proposed acquisition of MGM Resorts at $48.30 per share, questioning whether the board is acting in shareholders’ best interests. The offer price sits at the upper bound of our bull-case valuation, which we had assigned only a 20% probability, suggesting the bid could be viewed as opportunistic rather than fully fair. While the news creates a potential event-driven catalyst, it also introduces governance and litigation risk that may delay or derail the deal. The bid emerges as MGM’s core Las Vegas operations are still stabilizing and digital cash flows remain uneven, raising the stakes for a successful transaction. Investors now face a binary outcome: a completed deal at a modest premium or a return to fundamental-driven price discovery near our $32 attractive entry if the offer collapses.

Implication

A credible, completed deal would crystallize a premium to the pre-offer price and validate the bull case, yet the investigation signals that the offer’s adequacy is contested, increasing the odds of a protracted process or collapse. If the deal breaks down, the stock is likely to revert to its operational reality, where Strip recovery headwinds and high fixed obligations still weigh on equity value. For existing holders, the bid provides a near-term exit opportunity, but they should weigh the legal overhang against the premium. For potential buyers, the asymmetry of the bull case has diminished, as the offer price already reflects an optimistic scenario. Consequently, the thesis has shifted from a patient recovery play to a merger-arbitrage situation dependent on deal closure, reducing the appeal for fundamental investors.

Thesis delta

The investment thesis now incorporates a potential acquisition catalyst, but the offer price matches our previously assigned bull case, limiting additional upside. The investigation heightens deal uncertainty; without a higher bid, the risk/reward has evolved from an operational recovery bet to a binary M&A event. If the bid fails, the stock could quickly re-rate to its fundamental support in the low $30s, challenging the prior wait-and-watch stance.